3rd Circ. To Review Venue Ruling In GSK Birth Defects Case
By Kelly Knaub ( January 27, 2014, 2:52 PM EST) -- The Third Circuit agreed Friday to allow plaintiffs in a suit alleging GlaxoSmithKline PLC's antidepressant drug Paxil caused birth defects to appeal the company's removal of the case to federal court more than a year after the suit began....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.